MajorDirect oral anticoagulants (factor Xa inhibitors)×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Escitalopram (SSRI) depletes the platelet serotonin pool, impairing primary haemostasis. Apixaban inhibits factor Xa. Combined, GI bleeding risk rises 1.5- to 2-fold.
Symptoms
Gum bleeding, epistaxis, bruising without trauma, black tarry stools, blood in urine. Severe cases include gastrointestinal or intracranial haemorrhage.
Management
The combination is acceptable. PPI cover with pantoprazole is mandatory. Alternative antidepressants with minimal platelet effect: mirtazapine or agomelatine.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- PubMed: SSRIs increase bleeding risk when combined with antiplatelets and anticoagulants (2019)
- AEMPS: Ficha técnica de Eliquis 5 mg comprimidos recubiertos con película (apixabán) (2026)– AEMPS, CIMA (texto EMA), nº registro 111691009, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Escitalopram (nº registro 71430), sección 4.5 (2021)– AEMPS, CIMA, nº registro 71430, revisión 03/2021, sección 4.5